Here are four key points:
1. Even as the interest dropped, the days to cover came in at four.
2. The updated interest stood at 1.3 percent of the stocks floats.
3. The 52-week high of the share price is $45.84 and the 52-week low is $29.91.
4. With approximately 41.5 million shares in circulation, the company has a market cap of $1.79 billion.
More articles on GI/endoscopy:
CCFA, AGA & Janssen Biotech create new grant program for epigenetic research in IBD
Dr. Nolan Perez named Texas Lyceum director
GI/endoscopy company stock report – Feb.13, 2015
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
